Cargando…
Blocking the Metabolic Switch Toward Cytosolic 1C Flux: A Novel Therapeutic Approach for Tumors With Low SLC19A1 Expression
Autores principales: | Chen, Zhe, Zhou, Hong, Hu, Haoliang, Chen, Linxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072622/ https://www.ncbi.nlm.nih.gov/pubmed/35531073 http://dx.doi.org/10.3389/pore.2022.1610337 |
Ejemplares similares
-
Comprehensive Molecular Analyses of an SLC Family-Based Model in Stomach Adenocarcinoma
por: Yu, Tao, et al.
Publicado: (2022) -
Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma
por: Ying, Leqian, et al.
Publicado: (2021) -
SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma
por: Yang, Meng-Ling, et al.
Publicado: (2021) -
In Situ Analysis of mTORC1/C2 and Metabolism-Related Proteins in Pediatric Osteosarcoma
por: Mohás, Anna, et al.
Publicado: (2022) -
Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma
por: Li, Hui, et al.
Publicado: (2023)